Difference between revisions of "Carboplatin (Paraplatin)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m
m
Line 9: Line 9:
  
 
==Diseases for which it is used==
 
==Diseases for which it is used==
 +
<div style="column-count:3;-moz-column-count:3;-webkit-column-count:3">
 
*[[Adult T-cell leukemia-lymphoma]]
 
*[[Adult T-cell leukemia-lymphoma]]
 +
*[[Anaplastic glioma]]
 
*[[Bladder cancer]]
 
*[[Bladder cancer]]
 
*[[Breast cancer]]
 
*[[Breast cancer]]
Line 32: Line 34:
 
*[[Uterine cancer]]
 
*[[Uterine cancer]]
 
*[[Unknown primary]]
 
*[[Unknown primary]]
−
 
+
</div>
 
==Patient drug information==
 
==Patient drug information==
 
*[http://chemocare.com/chemotherapy/drug-info/carboplatin.aspx Carboplatin (Paraplatin) patient drug information (Chemocare)]<ref>[http://chemocare.com/chemotherapy/drug-info/carboplatin.aspx Carboplatin (Paraplatin) patient drug information (Chemocare)]</ref>
 
*[http://chemocare.com/chemotherapy/drug-info/carboplatin.aspx Carboplatin (Paraplatin) patient drug information (Chemocare)]<ref>[http://chemocare.com/chemotherapy/drug-info/carboplatin.aspx Carboplatin (Paraplatin) patient drug information (Chemocare)]</ref>
Line 44: Line 46:
 
!colspan="8" align="center" style="background-color:#0066FF"| '''Synonyms'''
 
!colspan="8" align="center" style="background-color:#0066FF"| '''Synonyms'''
 
|-
 
|-
−
|Abic Carboplatin
 
 
|Biocarb
 
|Biocarb
 
|Biocarbo
 
|Biocarbo
Line 50: Line 51:
 
|Biovinate
 
|Biovinate
 
|Blastocarb
 
|Blastocarb
−
|Blastocarb RU
 
−
|BO BEI
 
−
|-
 
 
|Bonaplatin
 
|Bonaplatin
 
|Boplatex
 
|Boplatex
 
|Carbo
 
|Carbo
−
|Carbo-Cell
+
|-
 
|Carbokem
 
|Carbokem
 
|Carbomedac
 
|Carbomedac
 
|Carbomerck
 
|Carbomerck
−
|Carbomerck Merk Hoei
 
−
|-
 
 
|Carboplat
 
|Carboplat
−
|Carboplatin-GRY
 
−
|Carboplatin-Teva
 
−
|Carboplatin Abic
 
−
|Carboplatin D-W
 
−
|Carboplatin DBL
 
 
|Carboplatine
 
|Carboplatine
−
|Carboplatine eurocept
 
−
|-
 
−
|Carboplatine Aguettant
 
−
|Carboplatin Ebewe
 
−
|Carboplatine Dakot
 
−
|Carboplatine Dakota
 
−
|Carboplatine Eurocept
 
−
|Carboplatine G GAM
 
−
|Carboplatine Mayne Pharma (BEN)
 
−
|Carboplatine Merck
 
−
|-
 
−
|Carboplatine Teva
 
−
|Carboplatin Hexal
 
−
|Carboplatin Lens
 
−
|Carboplatin Mayne
 
 
|Carboplatino
 
|Carboplatino
−
|Carboplatino Delta
 
−
|Carboplatino Ferrer
 
−
|Carboplatino Ferrer Farma
 
−
|-
 
−
|Carboplatino Filaxis
 
−
|Carboplatino Martian
 
−
|Carboplatino MAY
 
−
|Carboplatino Microsules
 
−
|Carboplatino Montedison
 
−
|Carboplatino Pharmacia
 
−
|Carboplatino PHU
 
−
|Carboplatino Raffo
 
−
|-
 
−
|Carboplatino Rontag
 
−
|Carboplatino Teva
 
−
|Carboplatin Sanofi-Synthelabo
 
 
|Carboplatinum
 
|Carboplatinum
 
|Carbosin
 
|Carbosin
 +
|-
 
|Carbotanil
 
|Carbotanil
 
|Carbotec
 
|Carbotec
 
|Carbotinol
 
|Carbotinol
−
|-
 
 
|Careptin
 
|Careptin
 
|Carplan
 
|Carplan
 
|Carplanil
 
|Carplanil
 
|Carpsol
 
|Carpsol
−
|cis-Diammine(1
 
−
|1-cyclobutanedicarboxylato)platinum(II)
 
 
|Crobextin
 
|Crobextin
 +
|-
 
|Cycloplatin
 
|Cycloplatin
−
|-
 
 
|Cycloplatinum
 
|Cycloplatinum
 
|Emorzim
 
|Emorzim
Line 123: Line 81:
 
|Ifacap
 
|Ifacap
 
|Kemocarb
 
|Kemocarb
−
|Mega Carboplatin
 
 
|-
 
|-
 
|Megaplatin
 
|Megaplatin
Line 130: Line 87:
 
|Neocarbo
 
|Neocarbo
 
|Oncocarb
 
|Oncocarb
−
|Oncocarbin AQ
 
−
|P&U Carboplatin
 
−
|Paraplatin AQ
 
−
|-
 
 
|Paraplatine
 
|Paraplatine
−
|Paraplatin RTU
 
 
|Pharmaplatin
 
|Pharmaplatin
 
|Platamine CS
 
|Platamine CS
 +
|-
 
|Platinwas
 
|Platinwas
 
|Ribocarbo
 
|Ribocarbo
−
|Ribocarbo-L
 
 
|Tecnocarb
 
|Tecnocarb
−
|-
 
−
|Trav Carboplatin
 
 
|Vancel
 
|Vancel
 
|CBDCA
 
|CBDCA
Line 159: Line 109:
  
 
[[Category:Adult T-cell leukemia-lymphoma medications]]
 
[[Category:Adult T-cell leukemia-lymphoma medications]]
 +
[[Category:Anaplastic glioma medications]]
 
[[Category:Bladder cancer medications]]
 
[[Category:Bladder cancer medications]]
 
[[Category:Breast cancer medications]]
 
[[Category:Breast cancer medications]]

Revision as of 02:33, 21 January 2018

General information

Class/mechanism: Platinum analog, alkylating-like, producing predominantly interstrand DNA crosslinks that are cell-cycle nonspecific.[1][2]

Route: IV
Extravasation: irritant

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp,Medscape, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Diseases for which it is used

Patient drug information

History of changes in FDA indication

  • 3/3/1989: Initial FDA approval

Also known as

Synonyms
Biocarb Biocarbo Bioplatinex Biovinate Blastocarb Bonaplatin Boplatex Carbo
Carbokem Carbomedac Carbomerck Carboplat Carboplatine Carboplatino Carboplatinum Carbosin
Carbotanil Carbotec Carbotinol Careptin Carplan Carplanil Carpsol Crobextin
Cycloplatin Cycloplatinum Emorzim Erbakar Ercar Fauldcarbo Ifacap Kemocarb
Megaplatin Nealorin Neocarb Neocarbo Oncocarb Paraplatine Pharmaplatin Platamine CS
Platinwas Ribocarbo Tecnocarb Vancel CBDCA

References

  1. ↑ 1.0 1.1 Carboplatin (Paraplatin) package insert
  2. ↑ Carboplatin (Paraplatin) package insert (locally hosted backup)
  3. ↑ Carboplatin AUC calculator
  4. ↑ Carboplatin (Paraplatin) patient drug information (Chemocare)
  5. ↑ Carboplatin (Paraplatin) patient drug information (UpToDate)
Retrieved from "https://hemonc.org/w/index.php?title=Carboplatin_(Paraplatin)&oldid=22791"